A convenient and rapid method to study enzymatic kinetics of steroid 5α-reductase inhibitors

Indian Journal of Pharmacology

Volumn 30, Issue 4, 1998, Pages 257-262

  Zu Yue, Sun ^a,b   Wei Jun, Zheng ^a   Jie, Feng ^a   Zeng Hong, Tu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Dihydrotestosterone; Epristeride; Finasteride; Steroid 5alpha reductase; Testosterone

Indexed keywords

EPRISTERIDE; FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; FEMALE; MALE; NONHUMAN; PROSTATE HYPERTROPHY; RAT; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0031678589     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 1A-adrenoceptor antagonist for the treatment of symptomatic benign prostatic hyperplasia. Drugs Today 1996; 2(Suppl. C) 1-12.
2. Horton R. Editorial: benign prostatic hyperplasia: new insights. J Clin Endocrinol Meteb 1992;74:504A-C.
3. Moore RJ, Gazak JM, Wilson JD. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate. J Clin Invest 1979;63:351-7.
4. Levy MA, Brandt M, Sheedy KM, Holt DA, Heaslip JI, Tril JJ, et al. Cloning, expression and functional characterization of type 1 and type 2 steroid 5α-reductase from Cynomolgus monkey: comparisons with human and rat isoenzymes. J Steroid Biochem Molec Biol 1995;52:307-19.
5. Guarna A, Pletti A, Catrambone F, Danza G, Marrucci A, Serio M, et al. Synthesis of a chemiluminsescent probe useful for the purification of steroid 5α-reductase. Bioorg Med Chem Lett 1996;6:1997-2002.
6. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994;63: 25-61.
7. Celler J, Kirschenbaum A, Lepor H, Levine AC.Therapeutic controversies: clinical treatment of benign prostatic hyperplasia. J Clin Endocrinol Metab 1995;80:745-7.
8. Prous J, Castaner J, Science P. Finasteride. Drugs Fut 1991; 16:996-1000.
9. Lamb JC, Levy MA, Johnson RK, Isaacs JT. Response of rat human prostatic cancers to the novel 5α-reductase inhibitor, SK&F 105657. Prostate 1992;21:15-34.
10. Boudon C, Lumbroso S, Labaccaro JM, Szarras-Czapnik M, Romer TE, Garandeau P. Molecular study of the 5α-reductase deficiency. J Clin Endocrinol Metab 1995;80:2149-53.
11. Russell DW, Wilson JD. Steroid 5α-reductase : two genes/ two enzymes. Annu Rev Biochem 1994;63:25-61.
12. Voet D, Voet JG, Biochemistry. 1st ed., New York, John Wiley & Sons, Inc.: 1990.
13. Metcaif BW, Hot DA, Levy MA, Erb JM, Heaslip JI, Brandt M. Potent inhibition of human steroid 5α-reductase (EC 1.3.1.30) by 3-androstene-3-carboxylic acids. Bioog Chem 1989;17:372-6.
14. Mathews CK, Holde KE, Biochemistry. California, Benjamin/ Cummings Company, Inc.: 1990.
15. Liang T, Heiss CE, Ostrove S, Rasmusson GH, Cheung A. Binding of a 4-Methyl-4-aza-steroid to 5α-reductase of rat liver and prostate microsomes. Endocrinology 1983; 112: 1460-8.
16. Zoppi S, Lechuga M, Motta M. Selective inhibition of the 5α-reductase of the rat epididymis. J Steroid Biochem Molec Biol 1992;42:509-14.
17. Guilbault GG, Enzymatic methods of analysis. London, Pergamon Press Ltd.: 1970.
18. Haeusler A, Allegrini PR, Biollaz M, Batzl C, Scheidegger-E, Bhatnagar AS. A new potent inhibitor of 5-alpha-reductase. J Steroid Biochem Mol Biol 1996;57:187-95.
19. Hirosumi J, Nakayama O, Fagan T, Sawada K, Chida N, Inami M, et al. FK143, a Novel Nonsteroidal Inhibitor of Steroid 5-alpha-Reductase: (1) In Vitro Effects of Human and Animal Prostatic Enzymes. J Steroid Biochem Mol Biol 1995;52:357-63.
20. Shao TC, Marcelli M, Kong A, Cunningham GR. Anti-androgen effects of the aromatase inhibitor, atamestane. J Androl 1995;16:100-7.
21. Laroque PA, Prahalada S, Molon-Noblot S, Cohen SM, Soper K, Duprat P, et al. Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: Effects of 5-alpha-reductase inhibitors. Prostate 1995;27: 121-8.